BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2984567)

  • 1. Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency.
    Shearer WT; Ritz J; Finegold MJ; Guerra IC; Rosenblatt HM; Lewis DE; Pollack MS; Taber LH; Sumaya CV; Grumet FC
    N Engl J Med; 1985 May; 312(18):1151-9. PubMed ID: 2984567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.
    Chuhjo T; Yachie A; Kanegane H; Kimura H; Shiobara S; Nakao S
    Am J Hematol; 2003 Apr; 72(4):255-8. PubMed ID: 12666136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation.
    Papadopoulos EB; Ladanyi M; Emanuel D; Mackinnon S; Boulad F; Carabasi MH; Castro-Malaspina H; Childs BH; Gillio AP; Small TN
    N Engl J Med; 1994 Apr; 330(17):1185-91. PubMed ID: 8093146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus-transformed B-cell line (DV-1) derived from bone marrow of a patient with severe combined immunodeficiency and immunoblastic lymphoma.
    Rosenblatt HM; Lewis DE; Sklar J; Cleary ML; Parikh N; Galili N; Ritz J; Shearer WT
    Pediatr Res; 1987 Apr; 21(4):331-7. PubMed ID: 3033590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EBV-associated B- and T-cell posttransplant lymphoproliferative disorders following primary EBV infection in a kidney transplant recipient.
    Yin CC; Medeiros LJ; Abruzzo LV; Jones D; Farhood AI; Thomazy VA
    Am J Clin Pathol; 2005 Feb; 123(2):222-8. PubMed ID: 15842046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of combined T- and B-cell depletion of allogeneic HLA-mismatched bone marrow graft on the magnitude and kinetics of Epstein-Barr virus load in the peripheral blood of bone marrow transplant recipients.
    Liu D; Tammik C; Zou JZ; Ernberg I; Masucci MG; Ringden O; Levitsky V
    Clin Transplant; 2004 Oct; 18(5):518-24. PubMed ID: 15344953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus associated lymphoproliferative diseases (B cell lymphoma) after transplantation.
    Garnier JL; Berger F; Betuel H; Vuillaume M; Chapuis-Cellier C; Blanc N; Faure JL; Dubernard JM; Lenoir G; Touraine JL
    Nephrol Dial Transplant; 1989; 4(9):818-23. PubMed ID: 2560533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus in a malignant lymphoproliferative disorder of B-cells occurring after thymic epithelial transplantation for combined immunodeficiency.
    Reece ER; Gartner JG; Seemayer TA; Joncas JH; Pagano JS
    Cancer Res; 1981 Nov; 41(11 Pt 1):4243-7. PubMed ID: 6272969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient immunodeficiency during asymptomatic Epstein-Barr virus infection.
    Bowen TJ; Wedgwood RJ; Ochs HD; Henle W
    Pediatrics; 1983 Jun; 71(6):964-7. PubMed ID: 6304613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Epstein-Barr virus infection with pneumonia transmitted by allogeneic bone marrow after transplantation.
    Teira P; Agbalika F; Bergeron A; Bernaudin F; Carmagnat M; Peffault de Latour R; Rocha V; Devergie A; Rabian C; Gluckman E; Ribaud P; Socié G; Robin M
    Clin Infect Dis; 2006 Oct; 43(7):892-5. PubMed ID: 16941371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-related lymphoproliferative disorders following bone marrow transplantation: an immunologic and genotypic analysis.
    Davey DD; Kamat D; Laszewski M; Goeken JA; Kemp JD; Trigg ME; Purtilo DT; Davis J; Dick FR
    Mod Pathol; 1989 Jan; 2(1):27-34. PubMed ID: 2537974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.
    Okamura T; Kishimoto T; Inoue M; Honda M; Yamashita N; Wakiguchi H; Yagita M; Hosoi G; Sako M; Yasui M; Yagi K; Kawa K
    Bone Marrow Transplant; 2003 Jan; 31(2):105-11. PubMed ID: 12621491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections.
    Jones JF; Shurin S; Abramowsky C; Tubbs RR; Sciotto CG; Wahl R; Sands J; Gottman D; Katz BZ; Sklar J
    N Engl J Med; 1988 Mar; 318(12):733-41. PubMed ID: 2831453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphotropic viruses, Epstein-Barr virus (EBV) and human T-cell lymphotropic virus-I (HTLV-I)/adult T-cell leukemia virus (ATLV), and HTLV-III/human immune deficiency virus (HIV) as etiological agents of malignant lymphoma and immune deficiency.
    Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S1-6. PubMed ID: 2881552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal B-cell lymphoproliferative syndrome in allogeneic marrow graft recipients. A clinical, immunobiological and pathological study.
    Simon M; Bartram CR; Friedrich W; Arnold R; Schmeiser T; Hampl W; Müller-Hermelink HK; Heymer B
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(5):307-19. PubMed ID: 1685038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
    Joncas JH; Wills A; Reece E; Fox Z
    Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation.
    Buckley RH; Schiff SE; Sampson HA; Schiff RI; Markert ML; Knutsen AP; Hershfield MS; Huang AT; Mickey GH; Ward FE
    J Immunol; 1986 Apr; 136(7):2398-407. PubMed ID: 2869085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of Epstein-Barr virus-induced human B-cell lymphoma in severe combined immunodeficient mice treated with CD3xCD19 bispecific antibodies, CD28 monospecific antibodies, and autologous T cells.
    Bohlen H; Manzke O; Titzer S; Lorenzen J; Kube D; Engert A; Abken H; Wolf J; Diehl V; Tesch H
    Cancer Res; 1997 May; 57(9):1704-9. PubMed ID: 9135012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyclonal B cell hyperplasia associated with Epstein-Barr virus causing acute renal allograft failure.
    Ludwin D; Quinonez G; Chernesky MA; Kay JM; Ali MA; Smith EK; Manning RF
    Clin Nephrol; 1985 Sep; 24(3):151-4. PubMed ID: 2994928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fractionated bone marrow transplantation in a case of severe combined immunodeficiency].
    García Rodríguez MC; Gómez-de la Concha E; Fontán G; Alba J; Guerrero J; Peña P; Ojeda JA
    An Esp Pediatr; 1982 Jul; 17(1):71-7. PubMed ID: 6753678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.